Publications by authors named "Josy Reiffers"

48Publications

MATWIN: bridging the gap between academic research and industry.

Hum Genomics 2015 Sep 16;9:23. Epub 2015 Sep 16.

MATWIN, Institut Bergonié, 229 cours de l'Argonne, CS 61283, 33076, Bordeaux cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40246-015-0045-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574017PMC
September 2015

Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells.

Mol Cell Oncol 2014 Oct-Dec;1(4):e970066. Epub 2014 Dec 31.

INSERM U916 VINCO; Institut Bergonié; Bordeaux, France; University of Bordeaux; Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/23723548.2014.970066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905221PMC
June 2016

[Professor John M. Goldman 1938-2013].

Bull Cancer 2014 Mar;101(3):224

View Article

Download full-text PDF

Source
March 2014

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J Clin Oncol 2014 Feb 9;32(5):424-30. Epub 2013 Dec 9.

Philippe Rousselot, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles; Aude Charbonnier, Institut Paoli Calmette, Marseille; Pascale Cony-Makhoul, Hôpital d'Annecy, Pringy; Philippe Agape, Hôpital Felix Guyon-Centre Hospitalier Universitaire en France (CHU) de la Réunion, La Réunion; Franck E. Nicolini, Centre Hospitalier Lyon Sud, Pierre-Bénite; Bruno Varet, Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes; Delphine Réa and Jean Michel Cayuela, Hôpital Saint-Louis, AP-HP, Paris; Martine Gardembas, CHU d'Angers, Angers; Gabriel Etienne and Josy Reiffers, Institut Bergonié; François-Xavier Mahon, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux; Lydia Roy, Joëlle Guilhot, and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM) Centres d'Investigation Clinique CHU de Poitiers, Poitiers; Martine Escoffre-Barbe, Centre Hospitalier Pontchaillou, Rennes; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Michel Tulliez, Hôpital Henri Mondor, AP-HP, Créteil; Stéphane Prost, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses; Marc Spentchian, Hôpital Mignot, Le Chesnay; and Jean Claude Chomel and Ali Turhan, INSERM U935, Université Poitiers et Paris Sud, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5797DOI Listing
February 2014

[The French Comprehensive Cancer Centers in the French oncology landscape].

Authors:
Josy Reiffers

Bull Cancer 2013 Jun;100(6):611-7

Unicancer, Présidence, 101, rue de Tolbiac, 75654 Paris Cedex 13, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2013.1762DOI Listing
June 2013

CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation.

Proc Natl Acad Sci U S A 2011 Nov 7;108(47):19072-7. Epub 2011 Nov 7.

Université Rennes-1, Institut de Recherche sur la Santé, l'Environnement et le Travail/Equipe Accueil Signalisation et Réponse aux agents infectieux et Chimiques 35043 Rennes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1116946108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223456PMC
November 2011

Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.

Exp Hematol 2008 Dec 14;36(12):1648-59. Epub 2008 Oct 14.

CHU Bordeaux, Hôpital Haut-Lévêque, Laboratoire d'Hématologie, Pessac, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2008.08.002DOI Listing
December 2008

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Blood 2008 Sep 4;112(5):2024-7. Epub 2008 Jun 4.

Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Inserm U876, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-147744DOI Listing
September 2008

[Transmission of medical information about patients who died of cancer to their heirs. Experience over 4 years and 57 cases].

Presse Med 2007 Oct 26;36(10 Pt 1):1350-3. Epub 2007 Mar 26.

Institut Bergonié, Bordeaux.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2007.01.036DOI Listing
October 2007

Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines.

Cancer 2005 Jan;103(1):102-10

Laboratoire Hematopoïése normale et pathologique FRE CNRS 2617, Université Victor Ségalen, Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.20758
Publisher Site
http://dx.doi.org/10.1002/cncr.20758DOI Listing
January 2005

Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.

Br J Haematol 2004 Jan;124(2):141-50

Bone Marrow Transplantation Laboratory, Bordeaux 2 University, 146 Rue Léo Saignat, 33076 Bordeaux cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04746.xDOI Listing
January 2004

Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemia.

Cancer Genet Cytogenet 2003 Jan;140(1):78-81

Laboratoire d'Hématologie, Centre Hospitalier et Universitaire de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00634-9DOI Listing
January 2003

Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis.

Clin Infect Dis 2003 Jan 6;36(2):229-33. Epub 2003 Jan 6.

Service de Médecine Interne, Hôpital Haut-Lévêque, Centre François Magendie, 33604 Pessac Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/345745DOI Listing
January 2003

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.

J Clin Oncol 2002 Nov;20(21):4324-30

Hematopoietic Stem Cell Transplant Unit, Hôpital Saint Louis, and Service d'Hématologie, CHU Saint-Antoine and European Data Management Office, Institut des Cordeliers, Paris, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2002.11.058
Publisher Site
http://dx.doi.org/10.1200/JCO.2002.11.058DOI Listing
November 2002

Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571.

Br J Haematol 2002 Oct;119(1):109-11

Laboratoire de Greffe de Moelle et Laboratoire d'hématologie, Université Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03708.xDOI Listing
October 2002

Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells.

Carcinogenesis 2002 Aug;23(8):1327-33

Bone Marrow Transplantation and Hematology Laboratories, CNRS UMR5540, EA 482 and GESNIT-EA 491, Victor Segalen Bordeaux-2 University, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/23.8.1327DOI Listing
August 2002